The autumn breeze is light and the sun is shining. On September 11, 2023, Wang Dongchun, deputy general manager of PTI Pharmaceutical, led the heads and backbones of quality, production, personnel administration, finance and other departments to Jiangsu Tasly Diyi Pharmaceutical for study and exchange.

Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Tasly Pharmaceutical Group Co., Ltd., located in the Biomedical Industrial Park of Qingjiangpu District, Huai'an City, covering an area of 323 acres and a construction area of about 87,700 square meters. Tasly Diyi Pharmaceutical Co., Ltd. is one of the top 100 chemical pharmaceutical enterprises of China Chemical Industry Pharmaceutical Association, a national high-tech enterprise, a postdoctoral research station, a science and technology small and medium-sized enterprise in Jiangsu Province, and a provincial anti-brain cancer drug engineering research center. It has won the title of Jiangsu Provincial Excellent Enterprise for Management Innovation, the first batch of pilot enterprises for the integration of industrialization and industrialization in Jiangsu Province, the Provincial Advanced Enterprise for the Demonstration and Creation of Intellectual Property Management Standardization, the National May Day Labor Award, the National Model Workers' Home, and the fourth batch of green manufacturing factories of the Ministry of Industry and Information Technology. In recent years, the company has adhered to innovation and continuous transformation of achievements, cultivated a new round of growth points, promoted breakthrough growth of economic indicators, and has become a key enterprise in the pharmaceutical industry in Jiangsu Province.

Accompanied by the leaders of Tasly Diyi Pharmaceutical, PTI Pharmaceutical and his entourage visited the factory facility environment, development history, corporate culture, production workshop, etc., and conducted in-depth communication with the corresponding departments and personnel. PTI Pharmaceutical will better learn from the good experience and practices of benchmarking enterprises, learn from and absorb new directions, ideas and measures for the development of PTI cause, and strengthen exchanges and cooperation with excellent enterprises such as Tasly Diyi in the follow-up development, so as to jointly contribute to the development of medicine and health in Jiangsu Province and the whole country.